发明公开
- 专利标题： MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS
- 专利标题（中）： 改良抗生素抗菌药物
-
申请号： EP15750880.5申请日： 2015-08-03
-
公开(公告)号： EP3174906A1公开(公告)日： 2017-06-07
- 发明人: VEGAS, Arturo J. , DOLOFF, Joshua C. , VEISEH, Omid , MA, Minglin , LANGER, Robert S. , ANDERSON, Daniel G.
- 申请人： Massachusetts Institute Of Technology , The Children's Medical Center Corporation
- 申请人地址： 77 Massachusetts Avenue Cambridge, MA 02139 US
- 专利权人： Massachusetts Institute Of Technology,The Children's Medical Center Corporation
- 当前专利权人： Massachusetts Institute Of Technology,The Children's Medical Center Corporation
- 当前专利权人地址： 77 Massachusetts Avenue Cambridge, MA 02139 US
- 代理机构： Potter Clarkson LLP
- 优先权： US201462032148P 20140801; US201562180415P 20150616
- 国际公布： WO2016019391 20160204
- 主分类号： C08B37/00
- IPC分类号： C08B37/00 ; A61K47/36 ; C12N5/00 ; C12N5/071
摘要：
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for coating of any material where reduced fibrosis is desired, such as encapsulated cells for transplantation and medical devices implanted or used in the body.
信息查询
